Enzyme therapy slows kidney function decline
Thursday, April 9, 2009 - 10:36
in Health & Medicine
For men with Fabry disease, enzyme replacement therapy (ERT) with agalsidase alfa slows deterioration of kidney function, reports a study in the online edition of the Journal of the American Society of Nephrology (JASN). 'The results provide further evidence that ERT with agalsidase alfa may slow the progression of kidney disease, provided that ERT is initiated early in the disease process,' comments Michael L. West, MD (Dalhousie University, Canada)...
Read the whole article on Science Centric
More from Science Centric
Related
- Enzyme therapy slows kidney function declineWed, 8 Apr 2009, 18:14:57 EDT
- Measurement of kidney function in children with kidney disease improvedTue, 20 Jan 2009, 17:42:56 EST
- Baking soda: For cooking, cleaning, and kidney health?Thu, 16 Jul 2009, 17:40:09 EDT
- Low thyroid function common in chronic kidney diseaseWed, 11 Jun 2008, 12:36:27 EDT
- Kidney function decline increases risk of heart failure and premature deathThu, 5 Nov 2009, 18:42:18 EST